The Community Outreach group at Cleveland Clinic’s Taussig Cancer Center sought input from people at local faith-based organizations to better understand and address the history of health disparities in the community.Read More
Ten Components of a High-Quality Lung Cancer Screening Program
Finding the balance point between benefit and harm is critical for a successful lung cancer screening program, and these 10 elements can help centers optimize care
Clinical Trial Explores SBRT and the Immune System in Pediatric Sarcoma
A new clinical trial at Cleveland Clinic is exploring the role of stereotactic body radiotherapy on the immune system of adolescent and young adult patients with metastatic or unresectable sarcoma.
Lutetium-PSMA for Metastatic Prostate Cancer (Podcast)
In a recent podcast, a Taussig Cancer Center physician discusses treatment options, trials, and more for managing metastatic castrate-resistant prostate cancer.
Robotic Radical Prostatectomy in Patients With a Hostile Surgical Abdomen
Excessive scar tissue in the abdomen has historically excluded patients from prostate surgery, owing to their higher risk of bowel injury. But a new technique is changing this paradigm.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Providing Psycho-Oncology Support (Podcast)
In this podcast, Cleveland Clinic’s Director of Psycho-Oncology addresses emotional supports for patients with cancer.
AI-Generated R.E.N.A.L.+ Score Surpasses Traditional Methods for Prediction of Oncologic Outcomes
An artificial intelligence-generated R.E.N.A.L.+ score — developed by a team of researchers at Cleveland Clinic — proves superior to the traditional scoring system for the prediction of renal oncologic outcomes.
Comprehensive Genomic Profiling Helps Accelerate Second-Line Therapy and Potentially Avoid Ineffective Adjuvant Therapy in Resected Early-Stage Lung Adenocarcinoma
Comprehensive genomic testing is beneficial for patients at all stages of lung adenocarcinoma, according to a recent study.
Gene Expression Signature Predicts Patients’ Response to Cisplatin
Researchers are analyzing gene expression signatures to better predict which therapy will work best for each patient with cancer.
Management of Lung Cancer Brain Metastases: An Update
Treatment goals in this setting are to extend survival, prevent neurological dysfunction and improve quality of life. Advances is surgical safety, stereotactic radiosurgery and systemic therapies have yielded mounting progress.
Data Point to Progress in Treating Anaplastic Thyroid Cancer
Newly published data from Cleveland Clinic’s 21-year experience treating ATCs provide reasons for optimism in the current era of targeted and immune therapies.